You are here

Biomarkers and Diagnostics

Diagnostic, prognostic and predictive biomarkers and diagnostic tools and methods are available for licensing and/or collaborative development.

Peptides with excellent affinity and selectivity for ɑvß6 have been identified and characterised.

Read more

The Tyrer-Cuzick model has been shown in independent studies to be the most consistently accurate when compared with other available breast cancer risk assessment tools.

Read more